H-1B sponsorship profile: Ribon Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Ribon Therapeutics, Inc filed 2 Labor Condition Applications covering 2 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (2 certified of 2 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Ribon Therapeutics, Inc’s H-1B petitions range from $128,594 at the low end to $148,526 at the high end, with a petition-weighted average of $138,560. That range reflects the mix of occupations the company sponsors, led by Senior Scientist, Computational Biology (1 petitions at $148,526 avg), followed by Scientist, Computational Biology/Bioinformatics. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Ribon Therapeutics, Inc is headquartered in Cambridge, MA under NAICS code 541714, and places H-1B workers across 1 state, most heavily in MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Ribon Therapeutics, Inc ranks. By H-1B petition volume, Ribon Therapeutics, Inc is #48,558 of 119,880 employers nationally and #2,213 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.